Isoxazolo-[3,4-d]-pyridazin-7-(6H)-one as a potential substrate for new aldose reductase inhibitors

被引:35
作者
Costantino, L
Rastelli, G
Gamberini, MC
Giovannoni, MP
Dal Piaz, V
Vianello, P
Barlocco, D
机构
[1] Ist Chim Farmaceut & Tossicol, I-20131 Milan, Italy
[2] Dipartimento Sci Farmaceut, I-41100 Modena, Italy
[3] Dipartimento Sci Farmaceut, I-50121 Florence, Italy
关键词
D O I
10.1021/jm981107o
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The isoxazolo-[3,4-d]-pyridazin-7-(6H)-one (2) and its corresponding open derivatives 5-acetyl-4-amino-(4-nitro)-6-substituted-3(2H)pyridazinones (3, 4) were used as simplified substrates for the synthesis of new aldose reductase inhibitors with respect to the previously reported 5,6-dihydrobenzo[h]cinnolin-3(2H)one-2 acetic acids (1). Moreover, a few derivatives lacking the 5-acetyl group were prepared. Several compounds derived from 2 displayed inhibitory properties comparable to those of Sorbinil. In this class the presence at position 6 of a phenyl carrying an electron-withdrawing substituent proved to be beneficial, independently from its position on the ring (5g,j-l). Acetic acid derivatives were more effective than propionic and butyric analogues. On the contrary, all the monocyclic compounds (6-8) were either inactive or only weakly active. The 3-methyl-4-(p-chlorophenyl)isoxazolo-[3,4-d]-pyridazin-7-(6H)-one acetic acid (5g), which proved to be the most potent derivative, was also investigated in molecular modeling studies, to assess possible similarities in its interaction with the enzyme, with respect to the model 1.
引用
收藏
页码:1894 / 1900
页数:7
相关论文
共 18 条
  • [1] Benzothiazol-2-ylcarboxylic acids with diverse spacers: A novel class of potent, orally active aldose reductase inhibitors
    Aotsuka, T
    Abe, N
    Fukushima, K
    Ashizawa, N
    Yoshida, M
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (13) : 1677 - 1682
  • [2] A WELL-BEHAVED ELECTROSTATIC POTENTIAL BASED METHOD USING CHARGE RESTRAINTS FOR DERIVING ATOMIC CHARGES - THE RESP MODEL
    BAYLY, CI
    CIEPLAK, P
    CORNELL, WD
    KOLLMAN, PA
    [J]. JOURNAL OF PHYSICAL CHEMISTRY, 1993, 97 (40) : 10269 - 10280
  • [3] APPLICATION OF THE MULTIMOLECULE AND MULTICONFORMATIONAL RESP METHODOLOGY TO BIOPOLYMERS - CHARGE DERIVATION FOR DNA, RNA, AND PROTEINS
    CIEPLAK, P
    CORNELL, WD
    BAYLY, C
    KOLLMAN, PA
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 1995, 16 (11) : 1357 - 1377
  • [4] A 2ND GENERATION FORCE-FIELD FOR THE SIMULATION OF PROTEINS, NUCLEIC-ACIDS, AND ORGANIC-MOLECULES
    CORNELL, WD
    CIEPLAK, P
    BAYLY, CI
    GOULD, IR
    MERZ, KM
    FERGUSON, DM
    SPELLMEYER, DC
    FOX, T
    CALDWELL, JW
    KOLLMAN, PA
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (19) : 5179 - 5197
  • [5] Synthesis, activity, and molecular modeling of a new series of tricyclic pyridazinones as selective aldose reductase inhibitors
    Costantino, L
    Rastelli, G
    Vescovini, K
    Cignarella, G
    Vianello, P
    DelCorso, A
    Cappiello, M
    Mura, U
    Barlocco, D
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (22) : 4396 - 4405
  • [6] DALPIAZ V, 1991, J PHARM SCI, V80, P341
  • [7] THE MIDAS DISPLAY SYSTEM
    FERRIN, TE
    HUANG, CC
    JARVIS, LE
    LANGRIDGE, R
    [J]. JOURNAL OF MOLECULAR GRAPHICS, 1988, 6 (01): : 13 - &
  • [8] THE ROLE OF ALDOSE REDUCTASE IN THE DEVELOPMENT OF DIABETIC COMPLICATIONS
    KADOR, PF
    [J]. MEDICINAL RESEARCH REVIEWS, 1988, 8 (03) : 325 - 352
  • [9] NOVEL, POTENT ALDOSE REDUCTASE INHIBITORS - 3,4-DIHYDRO-4-OXO-3-[[5-(TRIFLUOROMETHYL)-2-BENZOTHIAZOLYL]METHYL]-1-PHTHALAZINEACETIC ACID (ZOPOLRESTAT) AND CONGENERS
    MYLARI, BL
    LARSON, ER
    BEYER, TA
    ZEMBROWSKI, WJ
    ALDINGER, CE
    DEE, MF
    SIEGEL, TW
    SINGLETON, DH
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (01) : 108 - 122
  • [10] PEARLMAN DA, 1995, AMBER 4 1